A population study of 1310 women aged 45-64 years determined the prevalence of headache and migraine in the preceding year. To investigate the hypothesis that women with migraine had a higher mortality rate, these women were followed up nearly 12 years later. Unexpectedly, the mortality was found to be higher in women without headaches. Women with headaches and migraine had a relative risk of dying of 0 72 (95% confidence interval 0 52-100) compared with those without headaches.
Introduction
There is little information from epidemiological studies on the association of migraine or other headaches with mortality. Serious intracranial disease such as brain tumours and aneurysms are associated with headache but are uncommon in the general population. Attacks of migraine have been associated with neurological disturbances' which may rarely cause death. 2 3 Headaches accompany and precede cerebrovascular disease4 5 and also precede myocardial infarction. 6 In a study of women below 70 years with migraine Graham7 found risk ratios of 1 6 for high blood pressure, 6-6 for heart attack, and 1-9 for death but it is not clear how these data were obtained. If headache were associated with hypertension associations with morbidity and mortality would be expected. Epidemiological evidence, however, suggests only a very weak association, and probably hypertension accounts for only a small percentage of headache in the community. In 1979 these same women were followed up by home visiting to ascertain mortality. Survival was assumed if the subject or a close relative was interviewed or if a letter was received from the subject. For every death before the end of 1978 a certified copy of the death certificate was inspected. Causes of death were coded according to the International Classification of Diseases (ICD; 8th revision). Statistical analysis was carried out using the computer package GENSTAT,'0 as described."1 In particular, multiple logistic regression was used to assess the effect of various factors on the probability of dying in the follow up period.
Results
A total of 2932 women were followed up. Table I shows their age distribution and the proportions who at the time of the 1967 survey gave a history of headache and reported two or three features of migraine. The proportion of women who had had headache increased slightly with age to a maximum at 35-44 years and then declined. 
Discussion
Migraine can be a debilitating disease, and in view of the few published comments on mortality2-7 this analysis was undertaken to determine whether or not sufferers from migraine and other headaches have a higher than expected mortality.
A surprising finding (table II) was that the proportion of our cohort who were still alive in 1979 in the no headache group (82%) was lower than the proportion in any other group. The excess deaths in the no headache group were apparently mainly due to ischaemic heart disease and cerebrovascular accidents, two conditions previously believed to be associated with headache. Multiple logistic regression analysis showed that the relative risk of death was less in those with headache and probably less in those with migraine compared with other women of the same age.
These results were completely unexpected. We can state quite definitely that the women aged 45-64 years who had had headache and migraine in 1967 did not subsequently have an increased risk of dying.
There are two possible explanations. Firstly, although epidemiological studies show that the prevalence of headache does not increase with blood pressure, the reporting of headache may lead to measurement of the blood pressure. Thus patients with headache may be more likely to have hypertension diagnosed and treated. This might explain the reduction in mortality in women with headache. Secondly, the results of this follow up were based on a period prevalence of headache in the year before the survey and we do not know the lifetime history of headache of these women. The prevalence of headache and migraine declines with age, so that their presence is sometimes thought to indicate that the arteries are still youthful. Their disappearance may indicate that the arteries are aging and "hardening." Hence women with headaches and migraine and advancing arterial disease possibly lose their headaches earlier than those with less arterial disease, and these women would be expected to have a high mortality from cardiovascular disease. Thus it is possible that the higher mortality of the women who were without headache at the time of the original survey was due to the presence of ex-sufferers of headache and migraine in the no headache group. The survey did not determine those who had suffered migraine in the past, so that we cannot say whether women who had experienced migraine at any time in their lives had a lower mortality rate.
While either of these possibilities could explain our findings, we have no direct evidence, either way, from the present study. It is probably the first large scale follow up survey of headache in a population sample of women, and further studies are clearly desirable. The results of our study, despite the possible explanations, should give considerable reassurance to women with headache and migraine and to their clinical advisors.
